O’Melveny Worldwide

Hong Kong IPOs – Company Side:

  • Sinotau in its proposed Hong Kong IPO (ongoing)
  • Huahui Health in its proposed Hong Kong IPO (ongoing)
  • Zephyrm Biotech in its proposed Hong Kong IPO (ongoing)
  • S.F. Holding Co., Ltd. (6936.HK) in its approximately HK$5.8 billion IPO and listing on the Hong Kong Stock Exchange*
  • JL MAG RARE-EARTH CO., LTD. (6680.HK) in its approximately HK$4 billion IPO and listing on the Hong Kong Stock Exchange*
  • Mediwelcome Healthcare Management & Technology Inc. (2159.HK) in its approximately HK$160 million IPO and listing on the Hong Kong Stock Exchange*
  • Jiangsu Innovative Ecological New Materials Limited (2116.HK)* in its approximately HK$150 million IPO and listing on the Hong Kong Stock Exchange*
  • Inner Mongolia Energy Engineering Co., Ltd. (1649.HK) in its approximately HK$1.1 billion IPO and listing on the Hong Kong Stock Exchange*

Hong Kong IPOs – Sponsor Side:

  • CICC and CMS as joint sponsors in the approximately HK$600 million IPO and listing of QingSong Health Corporation (2661.HK) on the Hong Kong Stock Exchange*
  • CITICS and CICC as joint sponsors in the approximately HK$680 million IPO and listing of Guangzhou Innogen Pharmaceutical Group Co., Ltd. (2591.HK) on the Hong Kong Stock Exchange*
  • CICC as the sole sponsor in the approximately HK$460 million IPO and listing of Sunho Biologics, Inc. (2898.HK) on the Hong Kong Stock Exchange*
  • CITICS as the sole sponsor in the approximately HK$1.04 billion IPO and listing of XtalPi Inc. (2228.HK) on the Hong Kong Stock Exchange*
  • CICC and CITICS as joint sponsors in the A+H listing of JA Solar Technology Co., Ltd. on the Hong Kong Stock Exchange*
  • CITICS and Fosun International as joint sponsors in the proposed Hong Kong IPO of Boche Holding Limited (Cayman)*
  • Huatai International as the sole sponsor in the approximately HK$460 million IPO and listing of AuGroup (SHENZHEN) Cross-Border Business Co., Ltd. (2519.HK) on the Hong Kong Stock Exchange*
  • CICC as the sole sponsor in the approximately HK$310 million IPO and listing of Xiamen Yan Palace Bird's Nest Industry Co., Ltd. (1497.HK) on the Hong Kong Stock Exchange*
  • CICC as the sole sponsor in the approximately HK$640 million IPO and listing of Xikang Cloud Hospital Holdings Inc. (9686.HK) on the Hong Kong Stock Exchange*
  • CICC and GS as joint sponsors in the proposed Hong Kong IPO of Neusoft Medical*
  • CICC and China Securities as joint sponsors in the approximately HK$410 million IPO and listing of 3D Medicines Inc. (1244.HK) on the Hong Kong Stock Exchange*
  • CMBC International as the sole sponsor in the approximately HK$1.09 billion IPO and listing of UJU HOLDINGLIMITED (1948.HK) on the Hong Kong Stock Exchange*
  • Shenwan Hongyuan as the sole sponsor in the approximately HK$130 million IPO and listing of Desun Real Estate Investment Services Group Co., Ltd. (2270.HK) on the Hong Kong Stock Exchange*
  • China Securities as the sole sponsor in the HK$60 million IPO and listing of Doumob (1917.HK) on the Hong Kong Stock Exchange*
  • CICC, MS, BofA, GS, JPM as joint sponsors in the US$7.43 billion IPO and listing of Postal Savings Bank of China Co., Ltd. (1658.HK) on the Hong Kong Stock Exchange*

Other Capital Markets Experience

  • China Huaneng Group (Hong Kong) Treasury Management Holding Limited (5089.HK) in the offering of US$500 million subordinated guaranteed perpetual securities*
  • Newborn Town Inc. (9911.HK) in its approximately HK$350 million placing of new H shares under general mandate*
  • Newborn Town Inc. (9911.HK) in an equity acquisition transaction*
  • SINOPEC SEG (2386.HK) in its major transactions*
  • Qinghuangdao Port (3369.HK) in its major transactions*
  • Fusi Capital in its equity investment in an education company*
  • DSHL, Inc. in its Series B financing*
  • BAIC BJEV in its equity investment in a battery manufacturing company*

Compliance Matters:

  • Advised the following Hong Kong-listed companies on compliance matters, including: INT Medical Instruments (1501.HK), Fosun Pharma (2196.HK)*, Bank of Communications Co., Ltd. (3328.HK)*, China Merchants Bank Co., Ltd (3968.HK)*, Newborn Town Inc. (9911.HK)*, SINOPEC Engineering (Group) Co., Ltd. (2386.HK)*, Qinhuangdao Port Co., Ltd. (3369.HK)*, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)*, and E-Commodities Holdings Limited (fka. Winsway Enterprises Holding Limited) (1733.HK)*

* Work performed prior to joining O’Melveny

Languages

  • English
  • Mandarin Chinese

Admissions

  • New York

Education

  • Boston University School of Law, LL.M.
  • China University of Political Science and Law, LL.B.

Professional Activities

Bar Exam

  • Passed Chinese Bar Exam